Psilocybin Study Suggests Potential for Longevity Benefits
LOS ANGELES- New preclinical research indicates that psilocybin the active psychoactive compound in psychedelic mushrooms—may significantly extend lifespan in both human cells and aged mice. Published July 8, 2025, in npj Aging, the study found ...
Challenges Emerge Over Kentucky’s Medical Cannabis License Lottery
LOS ANGELES- A coalition of Kentucky-based businesses has filed legal proceedings challenging the fairness and constitutionality of the state’s April 2024 medical cannabis license lottery. The lawsuit, lodged in Jefferson Circuit Court on June 27, ...
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Rubicon Organics Appoints Glen Ibbott as Interim CFO
LOS ANGELES- Rubicon Organics Inc. a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...
Clampdown on Australian Medicinal Cannabis Prescribing Raises Questions on Effectiveness
LOS ANGELES- Health regulators in Australia recently issued reinforced guidance aimed at improving prescribing standards for medicinal cannabis, reflecting growing concerns over patient safety and industry conduct. The Australian Health Practitioner Regulation Agency (AHPRA), along ...
The Senator Who Legalized Consumable Hemp Now Wants to Ban It
WASHINGTON, D.C.–Senator Mitch McConnell (R-KY), once hailed as the architect of federal hemp legalization under the 2018 Farm Bill, is now backing efforts that could dismantle the very market he helped create. Industry insiders say ...
Canadian Court Sides with Psychedelic Therapy Advocates in Psilocybin Exemption Case
LOS ANGELES- A Canadian federal court has ordered Health Canada to revisit its denial of psilocybin exemptions for health-care professionals, marking a significant development in the country’s evolving drug policy landscape. The ruling stems from ...
